Scientists develop a paper-based device for detecting malaria in asymptomatic carriers, addressing challenges in remote regions.
The device uses microfluidic technology and mass spectrometry for sensitive and portable on-site testing, showcasing superior performance over traditional methods.
Field studies in Ghana demonstrate the device's high sensitivity of 96.5% in detecting malaria antigens, surpassing microscopy and rapid tests.
The device's innovative design prevents blood leakage, ensures reagent stability, and offers near-perfect specificity with minimal false positives.
It has potential for detecting other diseases by adapting antibody probes, showcasing versatility, low costs, and ease of production.
Discussions with Ghana's government and ongoing research aim to integrate the device into national malaria control strategies and expand diagnostic capabilities.
The breakthrough combines microfluidics, immunochemistry, and mass spectrometry, revolutionizing point-of-care testing and global health impact.
The study was published in Analytical Chemistry and conducted by The Ohio State University researchers, supported by the National Institute of Allergy and Infectious Diseases.
Key words: malaria detection, microfluidic paper device, mass spectrometry, asymptomatic infection, point-of-care testing, sub-Saharan Africa, portable diagnostics.
Tags: disease diagnostics, engineered paper device, field testing, innovative healthcare solutions, malaria surveillance, rapid testing methods, sub-Saharan Africa malaria control.